THERASOURCE

TheraSource is a growing biotech company founded in 2004 and located in the Greater New York area. Our mission is to develop novel anti-inflammatory therapeutics for the treatment of human diseases. Our founder and scientists have demonstrated the efficacy of several newly-discovered molecules in preclinical studies of various medical conditions including ischemic acute kidney injury (AKI), inflammatory bowel disease (IBD), acute ischemic stroke, acute radiation syndrome, shock and sepsis, leading to >250 peer-reviewed publications.